Indeed, the expression of PDL1 (146), a well-known immune checkpoint molecule, in cancer surface is controlled by tyrosine kinase pathways, including Src, which we have previously demonstrated are under the control of AQP5 (124, 148, 149). Here, AQP5 is linked to cancer.